Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Neuroendocrinol ; 11(11): 887-95, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10520140

RESUMO

Since the glucocorticoid receptor (GR) and/or mineralocorticoid receptor (MR) in the hippocampus have been implicated in cortisol feedback of the hypothalamus-pituitary-adrenal (HPA) axis, abnormalities in those receptors might underlie the hyperactivity of the HPA axis described in patients with major depression. Animal studies have shown that long-term in-vivo treatment with antidepressants up-regulates hippocampal GR and/or MR, but it is not clear whether this up-regulation is evoked through a direct action of antidepressants on these receptors. We therefore examined the direct effects of long-term antidepressant treatment on GR binding and the levels of GR messenger RNA (mRNA) in primary cultures of rat hippocampal neurones. The time course of the effects of the tricyclic antidepressants desipramine and amitriptyline on GR binding, as assessed by [3H]dexamethasone binding using RU 28362, a specific agonist for GR, showed a biphasic mode of stimulation: desipramine significantly increased the GR binding with 2-day exposure by 36% over that in controls and by 99% and 60% with 10- and 14-day exposures, respectively. Amitriptyline also led to a significant increase in GR binding, with peaks at 2 (by 60%) and 14 days of exposure (by 60%). The effects of 14-day treatment with desipramine required at least the first 4-day exposure, and the first 10-day exposure was required for the full effect. Northern blot analysis demonstrated that the GR mRNA level was significantly increased by 14-day treatment with desipramine (+142% over control), amitriptyline (+108%), mianserin (+124%), paroxetine (+42%) and sulpiride (+92%), but not with haloperidol. Immunocytochemistry for GR revealed that 2- or 14-day treatment with desipramine significantly increased the number of GR-positive cells with dominant immunoreactivity in the nuclei of granule cell-like neurones or in perikarya of pyramidal cell- and granule cell-like neurones. These findings suggest that tricyclic antidepressants directly increase hippocampal GR by short-term (2-day) and long-term (14-day) exposure, and that the increase by long-term exposure is evoked commonly with different classes of antidepressants through transcriptional up-regulation of GR expression.


Assuntos
Antidepressivos Tricíclicos/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/metabolismo , Neurônios/metabolismo , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/metabolismo , Amitriptilina/farmacologia , Animais , Células Cultivadas , Desipramina/farmacologia , Dexametasona/metabolismo , Haloperidol/farmacologia , Ketanserina/farmacologia , Mianserina/farmacologia , Paroxetina/farmacologia , Fentolamina/farmacologia , Propranolol/farmacologia , RNA Mensageiro/genética , Ensaio Radioligante , Ratos , Receptores de Glucocorticoides/efeitos dos fármacos , Receptores de Mineralocorticoides/genética , Receptores de Mineralocorticoides/metabolismo , Sulpirida/farmacologia , Transcrição Gênica/efeitos dos fármacos , Trítio
2.
Brain Res ; 834(1-2): 89-102, 1999 Jul 10.
Artigo em Inglês | MEDLINE | ID: mdl-10407097

RESUMO

A single cerebroventricular injection of ethacrynic acid (EA), a Cl(-)-ATPase inhibitor, induces generalized tonic-clonic convulsions in mice. To clarify whether such convulsive stimulus triggers a long-lasting rearrangement of the neural circuitry culminating in seizure susceptibility, we examined molecular, cellular and behavioral changes following the EA-induced seizure. The expression of immediate early gene c-fos mRNA as an index for cellular activation increased biphasically, with an early transient increase at 60 min and a late prolonged increase on the 10th to 14th day post-EA administration, most remarkably in the hippocampus and pyriform cortex. On the 14th day post-EA seizure, subconvulsive dose of kainic acid (5-17.5 mg/kg) caused severe (stage 5) seizure in 77% of the mice, with 70% mortality. In addition, the expression of nerve growth factor (NGF) also showed biphasic increases with close spatiotemporal correlation with c-fos expression. Moreover, the number of cell somata and the density of axon fibers of parvalbumin (PARV)-positive cells, a subpopulation of GABAergic interneurons, decreased in area dentata, CA1 and CA3 on the 7th and 14th day post-EA seizure. In area dentata and CA1, the density of glutamic acid decarboxylase (GAD)-positive cells also decreased on the 14th day. Thus, the transient EA-induced seizures appear to develop seizure susceptibility by causing damage of a subpopulation of inhibitory interneurons along with increases in the expression of c-fos and NGF in limbic structures.


Assuntos
Epilepsia/metabolismo , Fatores de Crescimento Neural/genética , Parvalbuminas/metabolismo , Proteínas Proto-Oncogênicas c-fos/genética , RNA Mensageiro/metabolismo , Animais , Convulsivantes/farmacologia , Suscetibilidade a Doenças , Epilepsia/induzido quimicamente , Epilepsia/patologia , Epilepsia/fisiopatologia , Ácido Etacrínico , Antagonistas de Aminoácidos Excitatórios/farmacologia , Imuno-Histoquímica , Interneurônios/metabolismo , Interneurônios/patologia , Masculino , Camundongos , Inibição Neural/fisiologia , Fatores de Tempo , Distribuição Tecidual/fisiologia
3.
Jpn J Antibiot ; 44(2): 213-22, 1991 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-2041161

RESUMO

Pharmacokinetic and clinical studies of cefpirome (CPR) in children were carried out, and the following results were obtained. 1. Peak serum levels were obtained at the end of drip infusion of 20.0, 17.5 and 6.8 mg/kg for 30 minutes and the half-lives were 1.93, 1.91 and 0.48 hours, respectively. 2. Urinary excretion rates in 6 hours were 40.0-96.2%. 3. Thirty-two patients including 17 with respiratory infections, 7 with urinary tract infections and 8 with skin and soft tissue infections were treated with CPR at 52.2-92 mg/kg per day by intravenous administration. Clinical effects were excellent in 12 cases, good in 13 cases, fair in 3 cases and unknown in 4 cases, and the overall efficacy rate was 89.3% (25 cases/28 cases). 4. Bacterial eradication rate was 93.8% (15 strains/16 strains). 5. Rash and diarrhea were found in 1 case each, and abnormal laboratory test values were found in 7 cases.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Cefalosporinas/uso terapêutico , Adolescente , Infecções Bacterianas/metabolismo , Cefalosporinas/farmacocinética , Criança , Pré-Escolar , Avaliação de Medicamentos , Feminino , Meia-Vida , Humanos , Lactente , Masculino , Infecções Respiratórias/tratamento farmacológico , Infecções Urinárias/tratamento farmacológico , Cefpiroma
4.
Jpn J Pharmacol ; 79(3): 359-68, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10230865

RESUMO

We tried to detect natriuretic peptide (NP) receptor (NPR-A and NPR-B) mRNAs in cultured rabbit retinal pigment epithelium (RPE) cells and examined the regulation of their expression in relation to subretinal fluid absorption or RPE cell proliferation. RPE cells from 2-4 passages were grown to confluence on microporous membranes and analyzed for levels of expression of receptor mRNAs by quantitative RT-PCR and Northern blotting. The expression of NPR-B mRNA was approximately tenfold higher than that of NPR-A mRNA. The expression of NPR-A mRNA was not affected by treatments that may change subretinal fluid transport, while that of NPR-B mRNA was inhibited by transmitters involved in light- and dark-adaptation such as dopamine and melatonin. Expression of NPR-B mRNA was also suppressed by platelet-derived growth factor and transforming growth factor-beta. Furthermore, atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP), ligands for NPR-A and B, respectively, inhibited the proliferation of RPE cells, as analyzed by incorporation of [3H]thymidine. These findings suggest that ANP may be involved in constitutive absorption of subretinal fluid and that NPs form an important regulatory system of proliferation in RPE cells.


Assuntos
Guanilato Ciclase/genética , Epitélio Pigmentado Ocular/metabolismo , Receptores do Fator Natriurético Atrial/genética , Acetazolamida/farmacologia , Animais , Fator Natriurético Atrial/farmacologia , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Dopamina/farmacologia , Fator 2 de Crescimento de Fibroblastos/farmacologia , Expressão Gênica/efeitos dos fármacos , Substâncias de Crescimento/farmacologia , Manitol/farmacologia , Melatonina/farmacologia , Peptídeo Natriurético Tipo C/farmacologia , Norepinefrina/farmacologia , Epitélio Pigmentado Ocular/citologia , Epitélio Pigmentado Ocular/efeitos dos fármacos , Fator de Crescimento Derivado de Plaquetas/farmacologia , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Coelhos , Fator de Crescimento Transformador beta/farmacologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa